Astellas US LLC

États‑Unis d’Amérique


 
Quantité totale PI 175
Rang # Quantité totale PI 7 370
Note d'activité PI 3/5.0    164
Rang # Activité PI 4 177
Parent Astellas Pharma Inc.
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

33 48
0 24
2 16
52
 
Dernier brevet 2024 - Anti-c5 agent for treatment of d...
Premier brevet 1987 - Dna sequences, recombinant dna m...
Dernière marque 2024 - izervay
Première marque 1989 - AMBISOME

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceutical preparations in the nature of ophthalmic preparations; pharmaceutical preparations...
P/S Providing healthcare information
P/S Provision of healthcare information
P/S Providing information to health care providers and patients about patient reimbursement and insur...
P/S Medical information relating to women's health.
P/S Medical information relating to women's health
P/S Medical information relating to women’s health.
P/S Promoting public awareness of patient advocacy organizations; charitable services, namely, organi...
P/S Providing medical information in the field of ophthalmology
P/S Providing medical information.
P/S Providing medical information
2023 P/S Business administration of health reimbursement arrangements; providing business information rega...
P/S providing medical information about VMS symptoms commonly associated with menopause
P/S Providing medical information; providing a patient engagement program that uses behavioral scienc...
P/S Providing medical information; providing an internet-based database of patient medical informatio...
P/S Pharmaceutical preparations in the nature of ophthalmic preparations; Pharmaceutical preparations...
Invention Abiraterone prodrugs. Sustained-release abiraterone prodrug formulations, methods, and kits for ...
P/S Educational services, namely, conducting seminars, conferences and classes in the field of heart ...
P/S Pharmaceutical preparations in the nature of ophthalmic preparations; pharmaceutical preparation...
Invention Anti-c5 agent for treatment of dry age-related macular degeneration (amd) or geographic atrophy s...
Invention Methods for treating or preventing ophthalmological conditions. The present invention relates to...
Invention Methods for treating or preventing ophthalmological conditions. The present invention relates to ...
P/S Educational services, namely, providing seminars and workshops in the field of healthcare. Provid...
P/S Educational services, namely, providing seminars and workshops to train and educate nurses on the...
Invention Method for treating or preventing idiopathic polypoidal choroidal vasculopathy (ipcv). A method ...
Invention Abiraterone prodrugs. Sustained-release abiraterone prodrug formulations, methods, and kits for p...
2022 P/S Dietary and nutritional supplements for women's general health and well-being; menopausal symptom...
P/S Pharmaceutical preparations, products and substances for the treatment and management of symptoms...
P/S Pharmaceutical preparations for the treatment and management of vasomotor symptoms and conditions...
P/S Educational services, namely, providing seminars and workshops in the field of healthcare. Provid...
P/S Educational services, namely, providing seminars and workshops in the field of healthcare. Provi...
2021 Invention Methods for treating ophthalmological conditions. The present invention relates to methods for t...
Invention Topical compositions for pain relief, manufacture and use. The present invention relates to TRPV1...
Invention Aptamer therapeutics useful in the treatment of complement-related disorders. The invention provi...
2020 Invention Topical acyclovir formulations and uses thereof. Provided herein are gel formulations of acyclovi...
2018 Invention Method for treating or preventing idiopathic polypoidal choroidal vasculopathy (ipcv). A method f...
2014 Invention Pain relief compositions, manufacture and uses. The present invention relates to TRPV1 selective ...
2013 Invention High concentration capsaicinoid pain relief composition. The present invention relates to a compo...
2011 Invention Tool for assessment of symptoms of irritable bowel syndrome. Methods of treating and/or diagnosi...
2010 Invention Tool for assessment of symptoms of irritable bowel syndrome. Methods of treating and/or diagnosin...
2005 Invention Methods of treating skin conditions using inhibitors of the cd2/lfa-3 interaction. Methods of us...
Invention Methods of predicting responsiveness to treatment. Methods and compositions are described for pre...
Invention Methods of treating viral disorders. Methods of treating viral disorders are disclosed.
Invention Soluble lfa-3 polypeptide for treating viral disorders. Methods of treating viral disorders are d...
Invention Methods of treating skin disorders. Methods of treating skin disorders are provided.
Invention Methods of treating skin disorders. Methods of treating skin disorders are provided.
2004 Invention Method for treating or preventing sclerotic disorders using cd-2 binding agents. Methods and comp...
Invention Methods of treating skin conditions using inhibitors of the cd2/lfa-3 interaction. Methods of usi...
Invention Methods for treating or preventing skin disorders using cd2-binding agents. Methods for treating ...